Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00737139 · ClinicalTrials.gov registry record · NA
Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine
A NA study, sponsored by Rush University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT00737139 is a NA study that was terminated before completion, run by Rush University Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT00737139, a NA study, was terminated before completion, sponsored by Rush University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study involves research. The purpose of this research is to formally investigate the hemostatic efficacy of epinephrine to minimize blood loss after total joint arthroplasty. It is unclear if using intra-articular injections of epinephrine in total joint replacement is associated with a decrease in post-operative blood loss. The initial hypothesis is: the use of intra-articular injection of epinephrine is associated with decreased post-operative blood loss.
Interventions
- PROCEDURE Peri-articular injection of marcaine/epinephrine
- PROCEDURE Peri-articular injection of marcaine alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00737139
The ClinicalTrials.gov registry entry for NCT00737139 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peri-articular injection of marcaine/epinephrine is the first listed.
NCT00737139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00737139 about?
NCT00737139 is a clinical study titled "Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine". This study involves research. The purpose of this research is to formally investigate the hemostatic efficacy of epinephrine to minimize blood loss after total joint arthroplasty. It is unclear if using intra-articular injections of epinephrine in total joint replacement is associated with a decreas...
What is the current status of trial NCT00737139?
This trial is currently terminated. It is a NA study. The enrollment target is 33 participants. The study started on 2008-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00737139?
The interventions under investigation include: Peri-articular injection of marcaine/epinephrine (PROCEDURE), Peri-articular injection of marcaine alone (PROCEDURE).
Who is sponsoring clinical trial NCT00737139?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.